Neoplasms, Nerve Tissue  >>  ICT-121  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ICT-121 / EOM Pharma
NCT02049489: A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Completed
1
20
US
ICT-121 DC vaccine
Precision Life Sciences Group
Glioblastoma Multiforme
03/17
03/17

Download Options